BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 16431304)

  • 21. Thiopurine methyltransferase gene polymorphisms in Chinese patients with inflammatory bowel disease.
    Cao Q; Zhu Q; Shang Y; Gao M; Si J
    Digestion; 2009; 79(1):58-63. PubMed ID: 19252404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of association between the ITPA 94C>A polymorphism and adverse effects from azathioprine.
    Gearry RB; Roberts RL; Barclay ML; Kennedy MA
    Pharmacogenetics; 2004 Nov; 14(11):779-81. PubMed ID: 15564886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene polymorphisms involved in manifestation of leucopenia, digestive intolerance, and pancreatitis in azathioprine-treated patients.
    Wroblova K; Kolorz M; Batovsky M; Zboril V; Suchankova J; Bartos M; Ulicny B; Pav I; Bartosova L
    Dig Dis Sci; 2012 Sep; 57(9):2394-401. PubMed ID: 22535280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of thiopurine-S-methyltransferase genotype on the adverse drug reactions to azathioprine in patients with inflammatory bowel diseases.
    Hlavaty T; Batovsky M; Balakova D; Pav I; Celec P; Gregus M; Zakuciova M; Hlista M; Horakova M; Desatova B; Koller T; Toth J; Kadasi L; Huorka M;
    Bratisl Lek Listy; 2013; 114(4):199-205. PubMed ID: 23514552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meta-analysis: Inosine triphosphate pyrophosphatase polymorphisms and thiopurine toxicity in the treatment of inflammatory bowel disease.
    Van Dieren JM; Hansen BE; Kuipers EJ; Nieuwenhuis EE; Van der Woude CJ
    Aliment Pharmacol Ther; 2007 Sep; 26(5):643-52. PubMed ID: 17697198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ITPA Activity in Adults and Children Treated With or Without Azathioprine: Relationship Between TPMT Activity, Thiopurine Metabolites, and Co-medications.
    Citterio-Quentin A; Moulsma M; Gustin MP; Boulieu R
    Ther Drug Monit; 2017 Oct; 39(5):483-491. PubMed ID: 28650902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. No induction of thiopurine methyltransferase during thiopurine treatment in inflammatory bowel disease.
    Lindqvist M; Hindorf U; Almer S; Söderkvist P; Ström M; Hjortswang H; Peterson C
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1033-7. PubMed ID: 17065060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of thiopurine S-methyltransferase genotypes in Japanese patients with inflammatory bowel disease.
    Ban H; Andoh A; Tanaka A; Tsujikawa T; Sasaki M; Saito Y; Fujiyama Y
    Intern Med; 2008; 47(19):1645-8. PubMed ID: 18827410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of genetic variants in TPMT, ITPA, and NUDT15 with azathioprine-induced myelosuppression in southwest china patients with autoimmune hepatitis.
    Miao Q; Yan L; Zhou Y; Li Y; Zou Y; Wang L; Bai Y; Zhang J
    Sci Rep; 2021 Apr; 11(1):7984. PubMed ID: 33846471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Genetic Polymorphisms on 6-Thioguanine Nucleotide Levels and Toxicity in Pediatric Patients with IBD Treated with Azathioprine.
    Lee MN; Kang B; Choi SY; Kim MJ; Woo SY; Kim JW; Choe YH; Lee SY
    Inflamm Bowel Dis; 2015 Dec; 21(12):2897-908. PubMed ID: 26332308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of thiopurine methyltransferase status with azathioprine side effects in Chinese patients with systemic lupus erythematosus.
    Chen D; Lian F; Yuan S; Wang Y; Zhan Z; Ye Y; Qiu Q; Xu H; Liang L; Yang X
    Clin Rheumatol; 2014 Apr; 33(4):499-503. PubMed ID: 24322830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of the NUDT15 gene and metabolites of azathioprine in Japanese patients with inflammatory bowel disease.
    Suzuki S; Uchiyama K; Motoi Y; Yoshii Y; Inoue Y; Kubota T; Odahara S; Ohtaki Y; Takami S; Ito Z; Sato N; Ohkusa T; Koido S; Saruta M
    BMC Gastroenterol; 2023 Jul; 23(1):239. PubMed ID: 37454061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of genotypes for thiopurine methyltransferase and inosine triphosphate pyrophosphatase with long-term clinical outcomes in Korean patients with inflammatory bowel diseases during treatment with thiopurine drugs.
    Jung YS; Cheon JH; Park JJ; Moon CM; Kim ES; Lee JH; Kim SW; Kim JH; Hong SP; Kim TI; Kim WH
    J Hum Genet; 2010 Feb; 55(2):121-3. PubMed ID: 19960028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thiopurine methyltransferase gene polymorphisms and activity in Chinese patients with inflammatory bowel disease treated with azathioprine.
    Zhu Q; Cao Q
    Chin Med J (Engl); 2012 Oct; 125(20):3665-70. PubMed ID: 23075721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NUDT15 variant is the most common variant associated with thiopurine-induced early leukopenia and alopecia in Korean pediatric patients with Crohn's disease.
    Lee YJ; Hwang EH; Park JH; Shin JH; Kang B; Kim SY
    Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):475-8. PubMed ID: 26735160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of thiopurine S-methyltransferase gene polymorphisms in patients with inflammatory bowel disease from the island of Crete, Greece.
    Coucoutsi C; Emmanouil G; Goulielmos G; Sfakianaki O; Koutroubakis IE; Kouroumalis EA
    Eur J Gastroenterol Hepatol; 2017 Nov; 29(11):1284-1289. PubMed ID: 28857898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adverse reactions to azathioprine cannot be predicted by thiopurine S-methyltransferase genotype in Japanese patients with inflammatory bowel disease.
    Takatsu N; Matsui T; Murakami Y; Ishihara H; Hisabe T; Nagahama T; Maki S; Beppu T; Takaki Y; Hirai F; Yao K
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1258-64. PubMed ID: 19682195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective evaluation of the pharmacogenetics of azathioprine in the treatment of inflammatory bowel disease.
    Ansari A; Arenas M; Greenfield SM; Morris D; Lindsay J; Gilshenan K; Smith M; Lewis C; Marinaki A; Duley J; Sanderson J
    Aliment Pharmacol Ther; 2008 Oct; 28(8):973-83. PubMed ID: 18616518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Limitations of extensive TPMT genotyping in the management of azathioprine-induced myelosuppression in IBD patients.
    Dewit O; Moreels T; Baert F; Peeters H; Reenaers C; de Vos M; Van Hootegem P; Muls V; Veereman G; Mana F; Van Outryve M; Holvoet J; Naegels S; Piessevaux H; Horsmans Y; Gala JL;
    Clin Biochem; 2011 Sep; 44(13):1062-1066. PubMed ID: 21723857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequency of thiopurine methyltransferase mutation in patients of Mediterranean area with inflammatory bowel disease and autoimmune disorders.
    Di Salvo A; Fabiano C; Mannara V; Dimarco M; Orlando A; Affronti M; Macaluso FS; Cottone M
    Dig Liver Dis; 2016 Dec; 48(12):1506-1509. PubMed ID: 27665263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.